I am a biotech scientist and founder of CEXAL Diagnostics, focused on rapid, configurable biosensing platforms for infection, inflammation and wellness. My work spans probe and assay design, biosensor engineering and reader development for at‑home and point‑of‑care use. CEXAL’s platform has been validated for the fast detection of biomarkers, nucleic acids, and whole bacteria, as well as antimicrobial susceptibility testing, and can be adapted for colourimetric, lateral‑flow, and handheld reader formats. I collaborate with industry to translate these technologies into practical consumer and clinical products.